Causal association between lipid-lowering drugs and sleep apnea syndrome: A drug-targeted mendelian randomization study

Sleep Med. 2024 Jun:118:113-114. doi: 10.1016/j.sleep.2024.03.043. Epub 2024 Apr 9.

Authors

Linyi Lai¹, Yaqiong Liu²

Affiliations

¹ Genetics & Biotechnology Lab, Ryan Institute, University of Galway, Galway, Ireland.
² Regenerative Medicine Institute (REMEDI), Biomedical Sciences Building, University of Galway, Galway, Ireland. Electronic address: y.liu14@universityofgalway.ie.

PMID: 38614867
DOI: 10.1016/j.sleep.2024.03.043

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Hypolipidemic Agents* / adverse effects
Hypolipidemic Agents* / therapeutic use
Mendelian Randomization Analysis*
Sleep Apnea Syndromes* / chemically induced
Sleep Apnea Syndromes* / genetics

Substances

Hypolipidemic Agents